All News

Following the 2018 FDA approval of GW Pharmaceuticals’ Epidiolex®, there has been increased interest in the development of cannabinoid-derived drug substances for innovative new therapies. We examine the state of the market and future potenti...

Pipeline diversification, emerging therapies and shifting customer demands are the real dynamics reshaping the contract manufacturing market, according to experts.

Appropriate asthma and COPD patients provided with a "more affordable alternative to appropriate".

Netherlands-based specialty pharmaceutical company Pharming has received US Food and Drug Administration (FDA) approval for its new biologics facility in the Netherlands which it says will ensure sufficient manufacturing capacity for its acute heredita...

Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform.

Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint.

Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges.

CDMO Bora Pharmaceuticals said Monday it has agreed to acquire GlaxoSmithKline's Mississauga, Ontario (Canada) facility, which produces approximately 50 different products for more than 100 markets worldwide.

Sai Life Sciences won two awards at the recently concluded 2nd SCMPro India Procurement Leadership Forum & Awards 2020, in the categories of Supply Risk Management and Supplier Relationship Management.

Sai Life Sciences received the ISO 14001:2015 (Environment management system) and ISO 45001:2018 (Occupational health and safety management system) certification for its R&D centre (Unit II), Manufacturing facility (Unit IV) and Corporate office.

Systech International (“Systech”) announced today that it has entered into a definitive agreement to be acquired by Dover Corporation.

FLAVOXALE® is a unique ingredient derived from the combination of an exclusive propolis extract (M.E.D. propolis), manuka honey and manuka essential oil.

Thermo Fisher Scientific said Tuesday it has agreed to buy Dutch molecular testing and diagnostics specialist Qiagen for €39 per share in cash, valuing the overall transaction at around USD 11.5 billion.

Biotech firm Gilead Sciences said Monday it is set to acquire clinical-stage oncology specialist Forty Seven in a transaction worth $4.9 billion.

The company’s immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.

Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, C2 Pharma, has expanded its advisory board with a new member.

Fujifilm Diosynth Biotechnologies (FDB) has started work on capacity expansion to support high throughput and large volume gene therapy products at its manufacturing facility in Texas, US, the Japanese bio-focused contract research and development orga...

The US Food and Drug Administration (FDA) accepts for review Pfizer and Eli Lilly's Biologics License Application (BLA) for tanezumab — a non-opioid treatment for patients with chronic pain due to moderate-to-severe osteoarthritis.

The Vanquish Core HPLC System maximizes the delivery of precise results with simple, seamless method transfer.

The White House task force and the US President will meet drug makers this afternoon to discuss "progress on a vaccine and cure".

IGH Flavours & Technology from Disproquima group, inaugurated last November its new headquarters and manufacturing plant in Murcia, Spain.

With the world’s attitude to tackling climate change arguably the global number one hot topic of 2019, the issue of sustainability is an emerging theme in pharmaceutical packaging.

The US Food and Drug Administration has reported the first case of a pharmaceutical drug shortage directly related to the global coronavirus (COVID-19) outbreak that is threatening to reach pandemic status.

Rescheduling will ensure all stakeholders can take part in a successful exhibition and conference.

A cooperation agreement between German pharma firm Merck KGaA and additive manufacturing specialist AMCM on 3D printing of tablets could eventually lead to scalable active pharmaceutical ingredient (API) formulation and faster, cheaper production, the ...

Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy.

Chinese CDMO WuXi Biologics has linked up with San Francisco biotech firm Vir Biotechnology to develop and manufacture human monoclonal antibodies (mAbs) to potentially treat coronavirus disease (COVID-19), the two firms said Tuesday.

Sai Life Sciences, today announced the appointment of Dr. Dean Edney as Senior Vice President and Global Head of Process Research & Development.

The study will evaluate the efficacy of SJX-653 in reducing the frequency and severity of VMS due to menopause, as well as improving measures of sleep and quality of life.

Unlocking the potential of Raman spectroscopy as a high throughput analytical technique for monitoring cell culture in mini bioreactors.

Cell and gene therapy service providers TrakCel and Ori Biotech have agreed a strategic partnership whereby TrakCel’s tracking software will be closely integrated with Ori’s automated platform to give users greater live supply chain visibility within c...

Italy’s Dipharma Francis has completed construction of a new cGMP manufacturing suite at its US subsidiary, Kalexsyn, strengthening its service offering and ensuring continuity across the product lifecycle from preclinical to commercialisation , the co...

Sanofi's plans to create a European company to manufacture and market active pharmaceutical ingredients (APIs) should help to balance the region's heavy reliance on sourcing them from Asian markets, the French pharmaceutical firm said Monday.

Identifying areas of unmet need to guide R&D strategy and shape drug pipelines

Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase.

ScentSational Technologies has selected CPHI on May 5, 2020 at the Philadelphia Convention Center to enable attendees to experience the Company’s latest innovation in multi-sensory branding for Dietary Supplements.

Tufts Center for the Study of Drug Development (CSDD) today published a white paper sharing study results that indicate Quotient Sciences’ Translational Pharmaceutics® platform reduces development times by more than 12 months and lo...

The future of value-added medicines will see gamification transforming the engagement of therapies.

Recipharm expects cost synergies of SEK 125 million (USD 12 million) from its recent acquisition of UK drug delivery firm Consort Medical and should realise them within the next 18 months, the Swedish contract research and development organisation (CDM...

The investment will support continued expansion into the fast-growing gene therapy segment, including new developments that will enable a range of best-in-class solutions for viral manufacturing.

Boehringer Ingelheim and Carebox Healthcare Solutions have launched a digital platform to provide patients, caregivers and doctors with information on the German drugmaker’s clinical trials.

A subsidiary of WuXi Biologics has signed a 20-year vaccine manufacturing contract worth around USD 3 billion with a global vaccine company, the Chinese contract development and manufacturing organisation (CDMO) said Tuesday.

The expansion will enable Putnam Associates to access the European market and to offer more localised support to its clients.

Deal sees 62 brands in multiple therapy areas and a manufacturing plant transfer to the company

Pharmaceutical companies need to change their mindset and focus more on delivering extra value from smart packaging rather than reducing the cost of their packaging operation, according to Alex Cole, senior strategic marketing manager at CPI.

Investment in resources to meet demand for large-scale supply of patented biocompatible surfactant.

Event move ensures extra precautions and safety measures taken

Acino Contract Manufacturing is pleased to announce a strategic partnership with UK-based Quay Pharma for the formulation and development of manufacturing processes for Oral Solid Dosage forms. The partnership will see both companies provide respective...

Developers of digital health tools designed to improve adherence to medicines need to make behavioural science the cornerstone of their strategy if they are to keep patients engaged and motivated, according to Paul Upham, Head of Smart Devices at Roche...

The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster.

Gene therapies have the potential to revolutionize treatment options for patients suffering from cancer, cystic fibrosis, heart disease, diabetes, Parkinson's, AIDS and Alzheimer's by replacing, inactivating or introducing genes into cells &mda...

The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.

The changing opportunities are attributed to rising GMP standards and increased regional harmonization.

EuTech has recently added two strong professionals in its Management Team. Shekhar Yerramilli has joined as COO and Rick Yglesias has joined as Head of Business Development.

Stevanato and Pfeiffer Vacuum will provide biopharma companies with advanced container closure integrity analysis and testing protocols.

Merck KGaA’s US life science arm, MilliporeSigma, has signed a global licence agreement with biologics technology firm ReForm Biologics to commercialize the latter’s proprietary excipients used in biotherapeutic formulations.

PCI Pharma Services has bought Toronto-based packaging and labelling specialist Bellwyck Pharma Services, adding four GMP-compliant facilities in the US, Germany and Canada to its global network, the CDMO announced Tuesday.

Biopharmaceutical outsourcing has increased markedly in recent years with a greater volume of work previously kept in-house being handed over to third party contractors

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Lonza will invest CHF 12 million (USD 12.3 million) in a catalytic convertor at its Visp manufacturing site to reduce annual emissions of carbon dioxide by 600,000 tons or 98%, the Switzerland-based contract development and manufacturing organisation (...

Rising pharmaceutical cost pressures and volume growth deceleration are forcing pharmaceutical companies to attempt to extract further value from existing medicines rather than solely pursuing new molecules, according to Aurelio Arias, Engagement Manag...

Zenith Technologies CEO, Joe Haugh, takes us through how the business has evolved this year, to better meet the needs of its customers, as well as the trends they see shaping the industry through 2020 and beyond.

CEO says the acquisition of Consort Medical will help to create a leading advanced delivery systems company.

The facility will triple the company’s cGMP clinical trial manufacturing capacity.

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.

The additional capacity will provide customers with shorter lead times and reduced transportation costs.

Bundling of competencies optimizes workflow of customer projects.

Delpharm and the Famar Group are pleased to announce the acquisition by Delpharm of 5 manufacturing sites belonging to Famar, in France, Canada and the Netherlands. The transaction signed today covers the French sites located in Orléans (Loiret), ...

With CPHI North America fast approaching, we asked several industry experts what they see as the main trends emerging across the US pharma supply chain this year.

Evolving patient needs, growing demand for traceability and increasing cost pressures have awakened innovation in the pharmaceutical packaging sector.

Trijardy XR is a once-daily therapy combining three well-established treatments in one pill.

Sai Life Sciences has initiated the recruitment of 300+ scientists for its upcoming integrated Research & Technology (R&T) centre in Hyderabad, India. This will result in doubling the full-time equivalents (FTEs) in the areas of discovery chemist...

A new drug candidate has been created by artificial intelligence (AI) for the very first time, with the exploratory research route to phase I clinical trials taking less than 12 months, considerably shorter than the typical four and a half years using ...

Amid heightened global concern over the recent coronavirus outbreak, Chinese CDMO WuXi Biologics has sought to reassure customers and patients that its drug supply lines have been unaffected.

ALPLApharma, a new brand of the global packaging specialist ALPLA Group, will introduce itself for the first time to industry professionals at the CPHI Worldwide exhibition.

Agreement will facilitate clinical trial translations in China.

Vetter has increased development capacity by bringing all its laboratories together into its 1,800 square metre Ravensburg site in Germany, the contract manufacturing and development organisation (CDMO) said Thursday.

The US Food and Drug Administration has issued India’s Dr Reddy’s Laboratories with five observations after a recent inspection at its active pharmaceutical ingredient (API) manufacturing plant at Srikakulam.

Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.

German company Merck KGaA is investing Euro 250 million in a Swiss biologics facility that bridges manufacturing and research.

As manufacturing industries continue to promote the diverse roles available in science, technology, engineering and mathematics (STEM) disciplines, we turn the spotlight on careers in chemical manufacturing…

Canadian investment firm Nabis Holdings said Tuesday it has agreed to form a joint venture with Israeli pharmaceutical company Panaxia to launch a range of cannabis-based pharmaceutical products in the US state of Arizona in the second half of 2020.

Cognate BioServices, a contract development and manufacturing organization specialising in cell and gene therapy, has completed its purchase of Cobra Biologics, a CDMO specialized in providing development and manufacturing services for plasmid DNA and ...

Biotech firm CNS Pharmaceuticals said Tuesday it has completed pilot manufacturing of a key active pharmaceutical ingredient for its brain tumor drug Berubicin, taking it closer to clinical trials.

Features new functionalities and capabilities making it versatile for a variety of both manual and automated microplate processing life science applications.

If proven safe and effective, mAb CIS43LS might be used prophylactically by tourists, medical workers or military personnel who travel to areas where malaria is common.

Indian CDMO Piramal Pharma Solutions said Tuesday it will invest C$25 million to expand the capacity of its Aurora facility in Canada by 10,500 square feet to house a new wing for manufacturing active pharmaceutical ingredients (APIs).

€250 million to be invested during the 2019-2022 period in new facility bridging research and manufacturing.

The programme will include the launch of next-generation respiratory inhalers, which will use near-zero Global Warming Potential propellants.

UK pharmaceutical firm AstraZeneca has committed to launching its next-generation asthma and chronic pulmonary disease inhaler with near-zero carbon propellants by 2025.

The single-use, ready-to-use, one-step nasal delivery device can deliver a formulation in an emergency situation quickly and easily.

A manifesto making recommendations on how to improve the uptake of vaccines and raise awareness of immunization among European has been presented to the European Commission.

The $470 million investment will support a state-of-the-art facility that produces injectable products and delivery devices.

The International Organization for Standardization (ISO) has published a new standard, named ISO 19577:2019 Critical substances potentially present in footwear and footwear components -- Determination of Nitrosamines.

No need to draw blood; researchers develop smart technology to diagnose diabetes and treat diabetic retinopathy.

The company targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system.

Quality laboratory data is vital to your pharmaceutical development program.

Sai Life Sciences will be in Tokyo for CPHI Japan 2020 during March 16-18, 2020. Please visit booth # 1C - 50 and explore opportunities for collaboration. To schedule an appointment, email [email protected]

Since 2018, oral dosage CDMO Skyepharma radically updated and expanded its packaging capabilities, opening new packaging lines equipped for serialization and aggregation.

In this exclusive interview, CURE Pharmaceutical COO Jessica Rousset explains her company’s dual pharmaceutical/nutraceutical approach and why the cannabinoid space is ripe for drug delivery innovation

Reig Jofre's oral, anti-wrinkle, moisturizing and firming cosmetic expands Forté Pharma's beauty range.

The potential acquisition will see UK CDMO NextPharma develop and broaden its technology offering into lipid-based finished dosage forms

CPHI Worldwide houses six zones representing each stage of the pharmaceutical supply chain - from APIs, machinery and packaging to outsourcing and biopharmaceuticals. Uniting over 45,000 visiting attendees and 2,500 international exhibitors, this ...

First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities.

Business to focus on intelligent and sustainable technologies.

BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program.

GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma

The French National Agency for Medicines and Health Product Safety (ANSM) has agreed that Innate Pharma’s Tellomak (lacutamab) Phase II trial can resume recruitment of new patients with relapsed/refractory Sézary syndrome and mycosis fungoides (MF) in ...

PF-05251749 complements the company’s pipeline of potential disease-modifying therapies for Alzheimer’s and Parkinson’s diseases.

Multiple options provide increased flexibility for sponsors.

Biopharma’s desire for fast, cheap production and cell and gene therapy firms’ need for consistency is shaping tech development in the sector.

The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products.

India’s Lupin Pharmaceuticals warned Monday it could face regulatory sanctions from the US Food and Drug Administration over its Tarapur active pharmaceutical ingredient (API) manufacturing facility.

Dr. Mark Bittinger has joined Sai Life Sciences as Vice President and Global Head of Biology. Mark will be based out of companys' new Discovery Biology facility in Cambridge, Massachusetts, USA, which provides exploratory biology capabilities to the...

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), announced the appointment of Jay Stella as Chief Business Officer, to lead the overall business development and program management for t...

CPHI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPHI, including CPHI North America—the only event to bring the entire North American pharmac...

Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis, and the advancement of regenerative medicine.

The US arm of generic and specialty pharma company Mylan Pharmaceuticals has recalled three lots of its heartburn drug Nizatidine in capsule form amid fears of possible nitrosamine contamination.

Includes:
* Spray pattern
* Plume geometry
* Droplet size distribution

Other tests:
* Priming and Repriming
* Dosage
* Dose uniformity

End-to-end robotic platform provides biotechnology companies, pharmaceutical corporations and academic centres with cost-effective and reproducible drug discovery data.